Ads
related to: pyruvate kinase- How Does It Work?
See how this treatment works
against pk deficiency.
- Community Support
Connect with people who are also
living with pk deficiency.
- Clinical Study Info
Learn more about the clinical
studies for this treatment.
- Healthcare Professionals
Visit this website if you are a
doctor seeking information.
- How Does It Work?
Search results
Europe Approves Agios Pharma's Mitapivat For Adult Pyruvate Kinase Deficiency Patients
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat)...
Agios (AGIO) Q4 Earnings Beat Estimates, Revenues Miss
Zacks via Yahoo Finance· 1 year agoAgios Pharmaceuticals, Inc. AGIO announced fourth-quarter 2022 earnings per share of 67 cents,...
Agios (AGIO) Q3 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 2 years agoAgios Pharmaceuticals (AGIO) posts narrower-than-expected Q3 loss while sales miss estimates. The...
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
Zacks via Yahoo Finance· 10 hours agoAgios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...
Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates
Zacks via Yahoo Finance· 3 months agoAgios Pharmaceuticals, Inc. AGIO reported a loss of $1.72 per share in fourth-quarter 2023, wider...
Agios (AGIO) Reports Narrower-Than-Expected Q3 Loss, Lags Sales
Zacks via Yahoo Finance· 7 months agoAgios Pharmaceuticals, Inc. AGIO reported a loss per share of $1.64 in third-quarter 2023, narrower...
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
InvestorPlace via Yahoo Finance· 1 month agoSome of the hottest opportunities can be found in biotech stocks to buy now. With innovation, mergers and acquisitions, major companies looking to...
J.P. Morgan Sees an ‘Attractive Entry Point’ in These 2 Stocks
TipRanks via Yahoo Finance· 2 years agoDid markets hit a turning point? The past couple of months brought us a seven-week losing streak in...
Rocket (RCKT) Surges 40% in 3 Months on Regulatory Updates
Zacks via Yahoo Finance· 6 months agoRocket Pharmaceuticals RCKT, a late-stage biotechnology company, has skyrocketed 40.1% in the past...
Top 20 Breakthrough Pharmaceutical Drugs of the Decade
Insider Monkey via Yahoo Finance· 8 months agoIn this article, we will take a detailed look at the Top 20 Breakthrough Pharmaceutical Drugs of the...
